Brain-Gut Yoga for Functional Dyspepsia and Gastroparesis (FD-GP)
FD-GP
Adaptation of the Yoga Skills Training for Relief of Nausea and Vomiting in Patients With Functional Dyspepsia and Gastroparesis
2 other identifiers
interventional
10
1 country
1
Brief Summary
The purpose of this research study is to assess whether using a yoga-based intervention in practice is feasible (possible) and acceptable to patients with Functional Dyspepsia and/or Gastroparesis (FD-GP).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 10, 2024
CompletedFirst Posted
Study publicly available on registry
December 13, 2024
CompletedStudy Start
First participant enrolled
June 18, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
April 23, 2026
October 1, 2025
12 months
December 10, 2024
April 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (12)
Screening Rate
Tracking the number of screened participants, those who are eligible, and the percent who agree to participate.
Week 0
Recruitment Rate
Total number of patients who enrolled and proportion of patients eligible who enrolled
Week 0
Retention Rate
Total number of participants who enrolled in the study who remained until completion
Week 2
Adherence Rate
Completion of 75% of the planned in-person sessions will be considered adherent; home practice will be tracked via daily logs sent back to study team electronically.
Week 2
Assessment Process Time
Amount of time needed for assessments.
Week 2
Acceptability of Intervention Score
Overall acceptability of intervention. Target acceptability ratings of at least 4 (agree/completely agree) on a scale of 1 to 5, with a score of 5 being the most acceptable.
Week 2
Client Satisfaction Questionnaire Score
Assesses satisfaction with treatment. Scores range from 8 to 32; higher scores indicate more satisfaction.
Week 2
Intervention Usability Scale Score
Measures intervention usability. Scores range from 0-100; a score of 70 or greater may be considered adequate.
Week 2
Visual analog scale for pain (VAS) score
Acute effects using a VAS scale of nausea and psychological distress ranging 0 (none at all) to 100 (as much as there could be) before and after each session to assess immediate relief of symptoms. Higher scores indicate more nausea and psychological distress.
Week 1, Week 2
Semi-Structured Interview
30-minute qualitative interview for perspectives on the barriers and facilitators to program engagement and suggestions for improvement, benefits of yoga intervention, and specific questions about format, usability, and burden of the intervention and current and future assessments. Key domains corresponding to the research goals will be developed based on the interview guide. All responses within each domain will be summarized to identify key findings which will be used to inform adaptation of the intervention.
Week 2
Semi-Structured Interview
30-minute qualitative interview for perspectives on the barriers and facilitators to program engagement and suggestions for improvement, benefits of yoga intervention, and specific questions about format, usability, and burden of the intervention and current and future assessments. Key domains corresponding to the research goals will be developed based on the interview guide. All responses within each domain will be summarized to identify key findings which will be used to inform adaptation of the intervention.
Week 3
Semi-Structured Interview
30-minute qualitative interview for perspectives on the barriers and facilitators to program engagement and suggestions for improvement, benefits of yoga intervention, and specific questions about format, usability, and burden of the intervention and current and future assessments. Key domains corresponding to the research goals will be developed based on the interview guide. All responses within each domain will be summarized to identify key findings which will be used to inform adaptation of the intervention.
Week 4
Study Arms (1)
Seated Yoga Intervention
EXPERIMENTALTwo one-hour yoga sessions with home practice administered individually by a yoga interventionist in GI clinic
Interventions
Two one-hour chair-based yoga sessions that will include gentle movements, breathing practices, and meditation, along with home practice.
Eligibility Criteria
You may qualify if:
- years and older
- Functional Dyspepsia or Gastroparesis (FP or GP) diagnosed by a physician using standard criteria
- Signed, written consent
You may not qualify if:
- Co-morbid Gastrointestinal or related disorders documents in the medical record: celiac disease, inflammatory Bowel Disease(active), gastrointestinal obstruction (if current in the last 6 months), any GI surgery within the last 6 months), chronic pancreatitis or any pancreatic or biliary disease, cirrhosis or any chronic liver disease other than metabolic associated hepatic disease (MASH), any malignancy (except skin cancer already resected and surgically in remission)
- A positive screen for the following: current psychotic symptoms, elevated suicide risk, active eating disorder, cognitive impairment, current harmful alcohol or substance use
- Does not understand English
- Underwent a regular yoga or other mediative movement practice (tai chi or qi gong) in the past 6 month
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Atrium Health Gastroenterology and Hepatology Kenilworth
Charlotte, North Carolina, 28204, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elyse Thakur, MD
Wake Forest University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 10, 2024
First Posted
December 13, 2024
Study Start
June 18, 2025
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
August 1, 2026
Last Updated
April 23, 2026
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share